PrEP in Substance Abuse Treatment: a Qualitative Study of Treatment Provider Perspectives

Overview

Journal Subst Abuse Treat Prev Policy

Publisher Biomed Central

Specialty Psychiatry

Date 2015 Jan 11

PMID 25575428

Citations 31

Authors

Anya Y Spector

Robert H Remien

Susan Tross

Affiliations

Soon will be listed here.

Abstract

Objectives: To examine substance abuse treatment providers' views on engaging clients in Pre-exposure Prophylaxis (PrEP) care and research trials.

Methods: Thirty-six medical and counseling service providers in six New York City outpatient substance abuse treatment programs participated in semi-structured qualitative interviews. Thematic content analysis was conducted by three coders, independently.

Results: Providers' perspectives toward PrEP were characterized by six salient themes: 1) Limited PrEP awareness. 2) Ambivalence about PrEP; 3) Perception of multiple challenges to delivery; 4) Uncertainty about clients' ability to be adherent to medication; 5) Concerns about medication safety/side effects; and 6) Perception of multiple barriers to conducting clinical trials.

Conclusions: Despite anticipated challenges, providers supported the introduction of PrEP in outpatient substance abuse treatment. Comprehensive training for providers is needed and should include PrEP eligibility criteria, strategies to support adherence and medication monitoring guidelines. Linkages between substance abuse treatment and primary care and/or enhancement of capacity within clinics to offer PrEP may help facilitate PrEP delivery. When conducting research in outpatient clinics, it is particularly important to protect client confidentiality.

Citing Articles

Lesbian, Gay, Bisexual, Transgender and Queer People's Experiences of Stigma Across the Spectrum of Inpatient Psychiatric Care: A Systematic Review.

Clark K, Jewell J, Sherman A, Balthazar M, Murray S, Bosse J Int J Ment Health Nurs. 2024; 34(1):e13455.

PMID: 39435958 PMC: 11771681. DOI: 10.1111/inm.13455.

Barriers to Alcohol Use Disorder Treatment in Patients with Alcohol-Associated Liver Disease.

Leko A, Leggio L Clin Liver Dis. 2024; 28(4):779-791.

PMID: 39362721 PMC: 11458136. DOI: 10.1016/j.cld.2024.06.012.

Clinical characteristics associated with problematic pornography use among individuals seeking treatment for opioid use disorder.

Stefanovics E, Kraus S, Madden L, Farnum S, Cannata E, Potenza M J Behav Addict. 2024; 13(4):938-946.

PMID: 39298267 PMC: 11737410. DOI: 10.1556/2006.2024.00037.

Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods.

Merle J, Zapata J, Quieroz A, Zamantakis A, Sanuade O, Mustanski B Addict Sci Clin Pract. 2024; 19(1):46.

PMID: 38816889 PMC: 11138081. DOI: 10.1186/s13722-024-00478-2.

Responding to the HIV Health Literacy Needs of Clients in Substance Use Treatment: The Role of Universal PrEP Education in HIV Health and Prevention.

Zhai Y, Isadore K, Parker L, Sandberg J Int J Environ Res Public Health. 2023; 20(19).

PMID: 37835163 PMC: 10572580. DOI: 10.3390/ijerph20196893.

References

Arnold E, Hazelton P, Lane T, Christopoulos K, Galindo G, Steward W . A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One. 2012; 7(7):e40603. PMC: 3394704. DOI: 10.1371/journal.pone.0040603. View

Ware N, Wyatt M, Haberer J, Baeten J, Kintu A, Psaros C . What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. J Acquir Immune Defic Syndr. 2012; 59(5):463-8. PMC: 3826169. DOI: 10.1097/QAI.0b013e31824a060b. View

Spreen W, Margolis D, Pottage Jr J . Long-acting injectable antiretrovirals for HIV treatment and prevention. Curr Opin HIV AIDS. 2013; 8(6):565-71. PMC: 3815009. DOI: 10.1097/COH.0000000000000002. View

Mimiaga M, White J, Krakower D, Biello K, Mayer K . Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts. AIDS Care. 2013; 26(6):684-93. PMC: 4053171. DOI: 10.1080/09540121.2013.845289. View

Chaiyachati K, Ogbuoji O, Price M, Suthar A, Negussie E, Barnighausen T . Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS. 2014; 28 Suppl 2:S187-204. DOI: 10.1097/QAD.0000000000000252. View

Des Jarlais D, Arasteh K, Perlis T, Hagan H, Abdul-Quader A, Heckathorn D . Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS. 2007; 21(2):231-5. DOI: 10.1097/QAD.0b013e3280114a15. View

Kelly J, Somlai A, DiFranceisco W, Otto-Salaj L, McAuliffe T, Hackl K . Bridging the gap between the science and service of HIV prevention: transferring effective research-based HIV prevention interventions to community AIDS service providers. Am J Public Health. 2000; 90(7):1082-8. PMC: 1446305. DOI: 10.2105/ajph.90.7.1082. View

Ross M, Hwang L, Zack C, Bull L, Williams M . Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. Int J STD AIDS. 2002; 13(11):769-74. DOI: 10.1258/095646202320753736. View

Ksobiech K . A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Educ Prev. 2003; 15(3):257-68. DOI: 10.1521/aeap.15.4.257.23828. View

10.

Kalichman S, Cain D, Zweben A, Swain G . Sensation seeking, alcohol use and sexual risk behaviors among men receiving services at a clinic for sexually transmitted infections. J Stud Alcohol. 2003; 64(4):564-9. DOI: 10.15288/jsa.2003.64.564. View

11.

McGowan J, Shah S, Ganea C, Blum S, Ernst J, Irwin K . Risk behavior for transmission of human immunodeficiency virus (HIV) among HIV-seropositive individuals in an urban setting. Clin Infect Dis. 2003; 38(1):122-7. DOI: 10.1086/380128. View

12.

Shelton J, Halperin D, Nantulya V, Potts M, Gayle H, Holmes K . Partner reduction is crucial for balanced "ABC" approach to HIV prevention. BMJ. 2004; 328(7444):891-3. PMC: 387490. DOI: 10.1136/bmj.328.7444.891. View

13.

Colfax G, Vittinghoff E, Husnik M, McKirnan D, Buchbinder S, Koblin B . Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. Am J Epidemiol. 2004; 159(10):1002-12. DOI: 10.1093/aje/kwh135. View

14.

Edlin B, Irwin K, Faruque S, McCoy C, Word C, Serrano Y . Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N Engl J Med. 1994; 331(21):1422-7. DOI: 10.1056/NEJM199411243312106. View

15.

Castilla J, Barrio G, Belza M, de la Fuente L . Drug and alcohol consumption and sexual risk behaviour among young adults: results from a national survey. Drug Alcohol Depend. 1999; 56(1):47-53. DOI: 10.1016/s0376-8716(99)00008-3. View

16.

Haley N, Roy E, Leclerc P, Boudreau J, Boivin J . HIV risk profile of male street youth involved in survival sex. Sex Transm Infect. 2004; 80(6):526-30. PMC: 1744937. DOI: 10.1136/sti.2004.010728. View

17.

Palepu A, Raj A, Horton N, Tibbetts N, Meli S, Samet J . Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems. J Subst Abuse Treat. 2005; 28(1):3-9. DOI: 10.1016/j.jsat.2004.09.002. View

18.

DeSimone J . Needle exchange programs and drug infection behavior. J Policy Anal Manage. 2005; 24(3):559-77. DOI: 10.1002/pam.20115. View

19.

Cassell M, Halperin D, Shelton J, Stanton D . Risk compensation: the Achilles' heel of innovations in HIV prevention?. BMJ. 2006; 332(7541):605-7. PMC: 1397752. DOI: 10.1136/bmj.332.7541.605. View

20.

Shoptaw S, Reback C . Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy. J Urban Health. 2006; 83(6):1151-7. PMC: 3261283. DOI: 10.1007/s11524-006-9119-5. View